Information de reference pour ce titreAccession Number: | 01222926-200407000-00009.
|
Author: | McMahon, Chris G. MB, BS, FACSHP *; Abdo, Carmita MD +; Incrocci, Luca MD ++; Perelman, Michael PhD [S]; Rowland, David PhD [P]; Waldinger, Marcel MD #; Xin, Zhong Cheng MD *,*
|
Institution: | (*)Australian Centre for Sexual Health, Sydney, Australia (+)Psiquiatria, Sao Paulo, Brazil (++)Department of Radiation Oncology, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands ([S])New York, USA ([P])Department of Psychiatry, Valparaiso University, Valparaiso, IN, USA (#)Department of Psychiatry, Leyenburg Hospital, The Hague, The Netherlands (**)Department of Urology, Peking University, Beijing, China
|
Title: | |
Source: | Journal of Sexual Medicine. 1(1):58-65, July 2004.
|
Abstract: | Introduction. Ejaculatory/orgasmic disorders, common male sexual dysfunctions, include premature ejaculation, inhibited ejaculation, anejaculation, retrograde ejaculation and anorgasmia.
Aim. To provide recommendations/guidelines concerning state-of-the-art knowledge for management of ejaculation/orgasmic disorders in men.
Methods. An International Consultation in collaboration with the major urology and sexual medicine associations assembled over 200 multidisciplinary experts from 60 countries into 17 committees. Committee members established specific objectives and scopes for various male and female sexual medicine topics. The recommendations concerning state-of-the-art knowledge in the respective sexual medicine topic represent the opinion of experts from five continents developed in a process over a 2-year period. Concerning the Disorders of Ejaculation/Orgasm in Men Committee, there were nine experts from six countries.
Main Outcome Measure. Expert opinion was based on grading of evidence-based medical literature, widespread internal committee discussion, public presentation and debate.
Results. Premature ejaculation management is dependent upon etiology. When secondary to ED, etiology-specific treatment is employed. When lifelong, initial pharmacotherapy (SSRI, topical anesthesia, PDE5 inhibitors) is appropriate. When associated with psychogenic/relationship factors, behavioral therapy is indicated. When acquired, pharmacotherapy and/or behavioral therapies are preferred. Retrograde ejaculation, diagnosed with spermatozoa and fructose in centrifuged post-ejaculatory voided urine, is managed by education, patient reassurance, pharmacotherapy or bladder neck reconstruction. Men with anejaculation or anorgasmia have a biologic failure of emission and/or psychogenic inhibited ejaculation. Men with age-related penile hypoanesthesia should be educated, reassured and be instructed in revised sexual techniques which maximize arousal.
Conclusions. More research is needed in understanding management of men with ejaculation/orgasmic dysfunction.
Copyright (C) 2004 Blackwell Publishing Ltd.
|
Author Keywords: | Ejaculation; Premature Ejaculation; Retrograde Ejaculation; Inhibited Ejaculation; Anejaculation; Selective Serotonon Re-Uptake Inhibitors; Psychotherapy.
|
References: | 1 Lipshultz LI, McConnell J, Benson GS. Current concepts of the mechanisms of ejaculation. Normal and abnormal states. J Reprod Med 1981;26: 499.
2 Ahlenius S, Larsson K, Svensson L, et al. Effects of a new type of 5-HT receptor agonist on male rat sexual behaviour. Pharmacol Biochem Behav 1981;15: 785.
3 Waldinger MD, Berendsen HH, Blok BF, et al. Premature ejaculation and serotonergic antidepressants-induced inhibited ejaculation: The involvement of the serotonergic system. Behav Brain Res 1998;92: 111.
4 Olivier B, van Oorschot R, Waldinger MD. Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour. Int Clin Psychopharmacol 1998;13(suppl 6): 9.
5 Waldinger MD. The neurobiological approach to early ejaculation. J Urol 2002;168: 2359.
6 Waldinger MD, Olivier B. Selective serotonin reuptake inhibitors (SSRIs) and sexual side effects: Differences in delaying ejaculation. In: Sacchetti E, Spano P, editors. Advances in preclinical and clinical psychiatry, Vol. I: Fluvoxamine: Established and emerging roles in psychiatric disorders. Milan, Italy: Excerpta Medica; 2000: 117-30.
7 Rowland DL, Cooper SE, Schneider M. Defining early ejaculation for experimental and clinical investigations. Arch Sex Behav 2001;30: 235.
8 Colpi GM, Fanciullacci F, Beretta G, et al. Evoked sacral potentials in subjects with true premature ejaculation. Andrologia 1986;18: 583.
9 Fanciullacci F, Colpi GM, Beretta G, et al. Cortical evoked potentials in subjects with true premature ejaculation. Andrologia 1988;20: 326.
10 Kaplan HS, Kohl RN, Pomeroy WB, et al. Group treatment of premature ejaculation. Arch Sex Behav 1974;3: 443.
11 Masters W, Johnson V. Human sexual inadequacy. Boston: Little Brown; 1970.
12 Spiess WF, Geer JH, O'Donohue WT. Premature ejaculation: Investigation of factors in ejaculatory latency. J Abnorm Psychol 1984;93: 242.
13 Strassberg DS, Kelly MP, Carroll C, et al. The psychophysiological nature of premature ejaculation. Arch Sex Behav 1987;16: 327.
14 Kilmann PR, Auerbach R. Treatments of premature ejaculation and psychogenic impotence: A critical review of the literature. Arch Sex Behav 1979;8: 81.
15 Schover L, Friedman J, Weiler S, et al. Multiaxial problem-oriented system for sexual dysfunctions. Arch Gen Psychiat 1982;39: 614.
16 Grenier G, Byers S. Operationalizing early or premature ejaculation. J Sex Res 2001;38: 369.
17 Semans JH. Premature ejaculation: New approach. South Med J 1956;49.
18 De Amicis LA, Goldberg DC, LoPiccolo J, et al. Clinical follow-up of couples treated for sexual dysfunction. Arch Sex Behav 1985;14: 467.
19 Hawton K, Catalan J, Martin P, et al. Long-term outcome of sex therapy. Behav Res Ther 1986;24: 665.
20 Althof SE, Levine SB, Corty EW, et al. A double-blind crossover trial of clomipramine for premature ejaculation in 15 couples. J Clin Psychiatry 1995;56: 402.
21 Waldinger MD, Hengeveld MW, Zwinderman AH, et al. Effect of SSRI antidepressants on ejaculation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 1998;18: 274.
22 McMahon CG. Treatment of early ejaculation with sertraline hydrochloride: A single-blind placebo controlled crossover study. J Urol 1998;159: 1935.
23 Waldinger MD, Zwinderman AH, Olivier B. Antidepressants and ejaculation: A double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. J Clin Psychopharmacol 2001;21: 293.
24 Atmaca M, Kuloglu M, Tezcan E, et al. The efficacy of citalopram in the treatment of early ejaculation: A placebo-controlled study. Int J Impot Res 2002;14: 502.
25 Waldinger M. Towards evidenced based drug treatment research on early ejaculation: A critical evaluation of methodology. Int J Impot Res 2003;15: 309.
26 Strassberg DS, de Gouveia Brazao CA, Rowland DL, et al. Clomipramine in the treatment of premature (early) ejaculation. J Sex Marital Ther 1999;25: 89.
27 McMahon CG, Touma K. Treatment of early ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies. J Urol 1999;161: 1826.
28 Kim SW, Paick JS. Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of early ejaculation. Urology 1999;54: 544.
29 Berkovitch M, Keresteci AG, Koren G. Efficacy of prilocaine-lidocaine cream in the treatment of early ejaculation. J Urol 1995;154: 1360.
30 Xin ZC, Choi YD, Lee SH, et al. Efficacy of a topical agent SS-cream in the treatment of early ejaculation: Preliminary clinical studies. Yonsei Med J 1997;38: 91.
31 Atikeler MK, Gecit I, Senol FA. Optimum usage of prilocaine-lidocaine cream in early ejaculation. Andrologia 2002;34: 356.
32 Abdel-Hamid IA, El Naggar EA, El Gilany AH. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 2001;13: 41.
33 Salonia A, Maga T, Colombo R, et al. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002;168: 2486.
34 Chen J, Mabjeesh NJ, Matzkin H, et al. Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation. Urology 2003;61: 197.
35 American Psychiatry Association. Diagnostic and statistical manual of mental disorders. DSM-IV. 4th edition. Washington DC: American Psychiatric Association; 1994.
36 Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994;151: 54.
37 Apfelbaum B. Retarded ejaculation: A much- misunderstood syndrome. In: Lieblum SR, Rosen RC, editors. Principles and practice of sex therapy: Update for the 1990's. 2nd edition. New York: Guilford Press; 1989: 168-206.
38 Fenichel O. The psychoanalytic theory of neurosis. New York: W. W. Norton; 1945.
39 Friedman M. Success phobia and retarded ejaculation. Am J Psychother 1973;27: 78.
40 Bancroft J. Central Inhibition of sexual response in the male: A theoretical perspective. Neurosci Biobehav Rev 1999;23: 763.
41 Perelman M. Sildenafil, sex therapy, and retarded ejaculation. Journal of Sex Education & Therapy 2001;26: 13.
42 Perelman M. Male orgasm. J Androl 2003;24.
43 Bors E, Comarr AE. Neurological disturbances of sexual function with special reference to 529 patients with spinal cord injury. Urol Surv 1960;10: 191.
44 Heiman JR, Meston CM. Empirically validated treatment for sexual dysfunction. In: Rosen R, Davis C, Ruppel H, editors. Annual review of sex research.
45 Delmonte M. Meditation as a clinical intervention strategy: A brief review. International Journal of Psychosomatics 1986;33: 9.
46 Fisher W. Multimodal sex therapy with a blind man suffering from retarded ejaculation. Special issue: Social work practice in sexual problems. Journal of Social Work & Human Sexuality 1986;4: 95.
47 Kaplan H. The new sex therapy. New York: Brunner/Mazel; 1974.
48 Pettitt G. Retarded ejaculation: Adjunctive treatment by hypnotically induced dreams in the context of sex therapy. Australian Journal of Clinical & Experimental Hypnosis 1982;10: 89.
49 Zgourides GWR. Retarded ejaculation: Overview and treatment implications. Journal of Psychology & Human Sexuality 1989;2: 139.
50 McCormick S, Olin J, Brotman AW. Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients. J Clin Psychiatry 1990;51: 383.
51 Ashton K, Hamer R, Rosen R. Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: A large-scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther 1997;23: 165.
52 Aizenberg D, Zemishlany Z, Weizman A. Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clin Neuropharmacol 1995;18: 320.
53 Balon R. Intermittent amantadine for fluoxetine-induced anorgasmia. J Sex Marital Ther 1996;22: 290.
54 Shrivastava R, Shrivastava S, Overweg N, et al. Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1995;15: 83.
55 Gitlin MJ. Treatment of sexual side effects with dopaminergic agents. J Clin Psychiatry 1995;56: 124.
56 Price J, Grunhaus LJ. Treatment of clomipramine-induced anorgasmia with yohimbine: A case report. J Clin Psychiatry 1990;51: 32.
57 Jacobsen FM. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry 1992;53: 119.
58 Othmer E, Othmer SC. Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder. J Clin Psychiatry 1987;48: 201.
59 Ashton A, Rosen R. Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 1998;59: 112.
60 Kara H, Aydin S, Yucel M, et al. The efficacy of fluoxetine in the treatment of early ejaculation: A double-blind placebo controlled study. J Urol 1996;156: 1631.
|
Language: | English.
|
Document Type: | ORIGINAL RESEARCH.
|
Journal Subset: | Clinical Medicine. Behavioral & Social Sciences.
|
ISSN: | 1743-6095
|
NLM Journal Code: | 101230693
|
Annotation(s) | |
|
|